List of Tables
    Table 1. Blood-Brain Barrier Transport Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Blood-Brain Barrier Transport Drugs Market Trends
    Table 3. Blood-Brain Barrier Transport Drugs Market Drivers
    Table 4. Blood-Brain Barrier Transport Drugs Market Challenges
    Table 5. Blood-Brain Barrier Transport Drugs Market Restraints
    Table 6. Global Blood-Brain Barrier Transport Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Blood-Brain Barrier Transport Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Blood-Brain Barrier Transport Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Blood-Brain Barrier Transport Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Blood-Brain Barrier Transport Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Blood-Brain Barrier Transport Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Blood-Brain Barrier Transport Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Blood-Brain Barrier Transport Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Blood-Brain Barrier Transport Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Blood-Brain Barrier Transport Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Blood-Brain Barrier Transport Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood-Brain Barrier Transport Drugs as of 2021)
    Table 18. Top Players of Blood-Brain Barrier Transport Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Blood-Brain Barrier Transport Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Blood-Brain Barrier Transport Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Blood-Brain Barrier Transport Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Blood-Brain Barrier Transport Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Blood-Brain Barrier Transport Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Blood-Brain Barrier Transport Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Blood-Brain Barrier Transport Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Blood-Brain Barrier Transport Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Blood-Brain Barrier Transport Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Blood-Brain Barrier Transport Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Blood-Brain Barrier Transport Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Blood-Brain Barrier Transport Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Blood-Brain Barrier Transport Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Blood-Brain Barrier Transport Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Blood-Brain Barrier Transport Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Blood-Brain Barrier Transport Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Cyclenium Corporation Information
    Table 43. Cyclenium Description and Business Overview
    Table 44. Cyclenium Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Cyclenium Blood-Brain Barrier Transport Drugs Product
    Table 46. Cyclenium Recent Development
    Table 47. BioAdvance Corporation Information
    Table 48. BioAdvance Description and Business Overview
    Table 49. BioAdvance Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. BioAdvance Product
    Table 51. BioAdvance Recent Development
    Table 52. EIP Pharma Corporation Information
    Table 53. EIP Pharma Description and Business Overview
    Table 54. EIP Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. EIP Pharma Product
    Table 56. EIP Pharma Recent Development
    Table 57. Bioasis Corporation Information
    Table 58. Bioasis Description and Business Overview
    Table 59. Bioasis Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Bioasis Product
    Table 61. Bioasis Recent Development
    Table 62. Immune Pharmaceuticals Corporation Information
    Table 63. Immune Pharmaceuticals Description and Business Overview
    Table 64. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Immune Pharmaceuticals Product
    Table 66. Immune Pharmaceuticals Recent Development
    Table 67. AZ Therapies Corporation Information
    Table 68. AZ Therapies Description and Business Overview
    Table 69. AZ Therapies Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. AZ Therapies Product
    Table 71. AZ Therapies Recent Development
    Table 72. Palobiofarma Corporation Information
    Table 73. Palobiofarma Description and Business Overview
    Table 74. Palobiofarma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Palobiofarma Product
    Table 76. Palobiofarma Recent Development
    Table 77. Bach Pharma Corporation Information
    Table 78. Bach Pharma Description and Business Overview
    Table 79. Bach Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Bach Pharma Product
    Table 81. Bach Pharma Recent Development
    Table 82. BrainsGate Corporation Information
    Table 83. BrainsGate Description and Business Overview
    Table 84. BrainsGate Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. BrainsGate Product
    Table 86. BrainsGate Recent Development
    Table 87. CarThera Corporation Information
    Table 88. CarThera Description and Business Overview
    Table 89. CarThera Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. CarThera Product
    Table 91. CarThera Recent Development
    Table 92. Dainippon Sumitomo Pharma Corporation Information
    Table 93. Dainippon Sumitomo Pharma Description and Business Overview
    Table 94. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Dainippon Sumitomo Pharma Product
    Table 96. Dainippon Sumitomo Pharma Recent Development
    Table 97. Fluorinov Pharma Corporation Information
    Table 98. Fluorinov Pharma Description and Business Overview
    Table 99. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Fluorinov Pharma Product
    Table 101. Fluorinov Pharma Recent Development
    Table 102. Fondazione Telethon Corporation Information
    Table 103. Fondazione Telethon Description and Business Overview
    Table 104. Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Fondazione Telethon Product
    Table 106. Fondazione Telethon Recent Development
    Table 107. Minoryx Corporation Information
    Table 108. Minoryx Description and Business Overview
    Table 109. Minoryx Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Minoryx Product
    Table 111. Minoryx Recent Development
    Table 112. NewGen Therapeutics Corporation Information
    Table 113. NewGen Therapeutics Description and Business Overview
    Table 114. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. NewGen Therapeutics Product
    Table 116. NewGen Therapeutics Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Blood-Brain Barrier Transport Drugs Customers List
    Table 120. Blood-Brain Barrier Transport Drugs Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Blood-Brain Barrier Transport Drugs Product Picture
    Figure 2. Global Blood-Brain Barrier Transport Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Blood-Brain Barrier Transport Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Blood-Brain Barrier Transport Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Blood-Brain Barrier Transport Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Blood-Brain Barrier Transport Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Blood-Brain Barrier Transport Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Blood-Brain Barrier Transport Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Blood-Brain Barrier Transport Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Blood-Brain Barrier Transport Drugs Report Years Considered
    Figure 11. Product Picture of Carrier-mediated Transport
    Figure 12. Product Picture of Receptor-mediated Transport
    Figure 13. Product Picture of Absorptive-mediated Transport
    Figure 14. Product Picture of Active Efflux Transport
    Figure 15. Product Picture of Others
    Figure 16. Global Blood-Brain Barrier Transport Drugs Market Share by Type in 2022 & 2028
    Figure 17. Global Blood-Brain Barrier Transport Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 20. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Blood-Brain Barrier Transport Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 22. United States Blood-Brain Barrier Transport Drugs Market Share by Type in 2022 & 2028
    Figure 23. United States Blood-Brain Barrier Transport Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Blood-Brain Barrier Transport Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 26. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Blood-Brain Barrier Transport Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 28. Product Picture of Alzheimer's Disease
    Figure 29. Product Picture of Epilepsy
    Figure 30. Product Picture of Parkinson's Disease
    Figure 31. Product Picture of Multiple Sclerosis
    Figure 32. Product Picture of Hunter's Syndrome
    Figure 33. Product Picture of Brain Cancer
    Figure 34. Product Picture of Others
    Figure 35. Global Blood-Brain Barrier Transport Drugs Market Share by Application in 2022 & 2028
    Figure 36. Global Blood-Brain Barrier Transport Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. Global Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 39. Global Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. Global Blood-Brain Barrier Transport Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. United States Blood-Brain Barrier Transport Drugs Market Share by Application in 2022 & 2028
    Figure 42. United States Blood-Brain Barrier Transport Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 43. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 44. United States Blood-Brain Barrier Transport Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 45. United States Blood-Brain Barrier Transport Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 46. United States Blood-Brain Barrier Transport Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 47. North America Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. North America Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. U.S. Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Canada Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Europe Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Europe Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. Germany Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. France Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.K. Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Italy Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Russia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 59. Asia-Pacific Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 60. China Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Japan Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. South Korea Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. India Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Australia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Taiwan Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Indonesia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Thailand Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Malaysia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Philippines Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Latin America Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Latin America Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Mexico Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Brazil Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Argentina Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 76. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 77. Turkey Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Saudi Arabia Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 79. U.A.E Blood-Brain Barrier Transport Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 80. Blood-Brain Barrier Transport Drugs Value Chain
    Figure 81. Blood-Brain Barrier Transport Drugs Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed